These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25398715)

  • 1. Chemoreflex physiology and implications for sleep apnoea: insights from studies in humans.
    Mansukhani MP; Wang S; Somers VK
    Exp Physiol; 2015 Feb; 100(2):130-5. PubMed ID: 25398715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoreflexes--physiology and clinical implications.
    Kara T; Narkiewicz K; Somers VK
    Acta Physiol Scand; 2003 Mar; 177(3):377-84. PubMed ID: 12609009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid body chemoreflex: a driver of autonomic abnormalities in sleep apnoea.
    Prabhakar NR
    Exp Physiol; 2016 Aug; 101(8):975-85. PubMed ID: 27474260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea.
    Morgan BJ; Teodorescu M; Pegelow DF; Jackson ER; Schneider DL; Plante DT; Gapinski JP; Hetzel SJ; Dopp JM
    Exp Physiol; 2018 Jul; 103(7):941-955. PubMed ID: 29750475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep apnoea and hypertension: role of chemoreflexes in humans.
    Smith ML; Pacchia CF
    Exp Physiol; 2007 Jan; 92(1):45-50. PubMed ID: 17099063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases.
    Giannoni A; Borrelli C; Gentile F; Sciarrone P; Spießhöfer J; Piepoli M; Richerson GB; Floras JS; Coats AJS; Javaheri S; Emdin M; Passino C
    Eur J Heart Fail; 2023 May; 25(5):642-656. PubMed ID: 36907827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep apnoea and the heart.
    Lévy P; Ryan S; Oldenburg O; Parati G
    Eur Respir Rev; 2013 Sep; 22(129):333-52. PubMed ID: 23997061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective carotid body ablation in experimental heart failure: a new therapeutic tool to improve cardiorespiratory control.
    Del Rio R; Andrade DC; Marcus NJ; Schultz HD
    Exp Physiol; 2015 Feb; 100(2):136-42. PubMed ID: 25398714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoreflex failure and sleep-disordered breathing in familial dysautonomia: Implications for sudden death during sleep.
    Palma JA; Gileles-Hillel A; Norcliffe-Kaufmann L; Kaufmann H
    Auton Neurosci; 2019 May; 218():10-15. PubMed ID: 30890343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep-Disordered Breathing-Do We Have to Change Gears in Heart Failure?
    Cowie MR
    Curr Heart Fail Rep; 2016 Oct; 13(5):255-265. PubMed ID: 27640202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF2 mediates enhanced chemoreflex sensitivity, disordered breathing and autonomic dysregulation in heart failure.
    Marcus NJ; Del Rio R; Ding Y; Schultz HD
    J Physiol; 2018 Aug; 596(15):3171-3185. PubMed ID: 29023738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms.
    Arnaud C; Bochaton T; Pépin JL; Belaidi E
    Arch Cardiovasc Dis; 2020 May; 113(5):350-358. PubMed ID: 32224049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoreflexes, sleep apnea, and sympathetic dysregulation.
    Mansukhani MP; Kara T; Caples SM; Somers VK
    Curr Hypertens Rep; 2014 Sep; 16(9):476. PubMed ID: 25097113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on cardiovascular effects of obstructive sleep apnoea syndrome.
    Uyar M; Davutoglu V
    Postgrad Med J; 2016 Sep; 92(1091):540-4. PubMed ID: 27317753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parasympathetic hyperresponsiveness and bradyarrhythmias during apnoea in hypertension.
    Somers VK; Dyken ME; Mark AL; Abboud FM
    Clin Auton Res; 1992 Jun; 2(3):171-6. PubMed ID: 1498563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension.
    Narkiewicz K; Somers VK
    J Hypertens; 1997 Dec; 15(12 Pt 2):1613-9. PubMed ID: 9488212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chemoreflex model of relation between blood pressure and heart rate in sleep apnea syndrome.
    Van den Aardweg JG; van Steenwijk RP; Karemaker JM
    Am J Physiol; 1995 May; 268(5 Pt 2):H2145-56. PubMed ID: 7771565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous assessment of central and peripheral chemoreflex regulation of muscle sympathetic nerve activity and ventilation in healthy young men.
    Keir DA; Duffin J; Millar PJ; Floras JS
    J Physiol; 2019 Jul; 597(13):3281-3296. PubMed ID: 31087324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic nerve activity in obstructive sleep apnoea.
    Narkiewicz K; Somers VK
    Acta Physiol Scand; 2003 Mar; 177(3):385-90. PubMed ID: 12609010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.